Xiaofeng Chen
Impact in
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid
-
- Pharmacological Effects of Natural Compounds
Papers in
-
- Aortic aneurysm repair treatments 3
- Gastric Cancer Management and Outcomes 2
- Oncology 5
- Cancer Immunotherapy and Biomarkers 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Gang Liu (1 shared paper)Xueli Li (1 shared paper)Jiayuan Zhao (1 shared paper)Dayu Huang (3 shared papers)Qinyun Ma (1 shared paper)Huijun Zhang (1 shared paper)Jilu Ye (1 shared paper)Haotian Zhang (1 shared paper)
- Journals
- Current Microbiology (1 paper)World Journal of Surgery (1 paper)Non-coding RNA Research (1 paper)Journal of Agricultural and Food Chemistry (1 paper)International Immunopharmacology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiaofeng Chen
24 papers receiving 255 citations
Peers
Comparison fields: 5 of 68
- Nephrology 45
- Pharmacology 17
- Pulmonary and Respiratory Medicine 55
- Oncology 34
- Molecular Biology 86
Countries citing papers authored by Xiaofeng Chen
This map shows the geographic impact of Xiaofeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Chen more than expected).
Fields of papers citing papers by Xiaofeng Chen
This network shows the impact of papers produced by Xiaofeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Chen. The network helps show where Xiaofeng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofeng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 43 | |
| 2 | 2022 | 39 | |
| 3 | 2017 | 28 | |
| 4 | 2016 | 18 | |
| 5 | 2021 | 18 | |
| 6 | 2014 | 15 | |
| 7 | 2013 | 12 | |
| 8 | 2009 | 10 | |
| 9 | 2016 | 10 | |
| 10 | 2024 | 9 | |
| 11 | [Efficacy and safety of non-invasive positive pressure ventilation in the care of dyspnea after cardiac surgery]. | 2007 | 9 |
| 12 | 2015 | 7 | |
| 13 | 2024 | 6 | |
| 14 | 2020 | 5 | |
| 15 | 2023 | 5 | |
| 16 | Experimental Research of Radix Glycyrrhiza on Reducing Hepatic Toxicity Induced by Rhizoma Dioscoreae Bulbiferae | 2011 | 4 |
| 17 | 2020 | 4 | |
| 18 | 2017 | 4 | |
| 19 | 2013 | 4 | |
| 20 | 2025 | 2 |
About Xiaofeng Chen
Xiaofeng Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Immunology and Surgery, having authored 28 papers that have together received 257 indexed citations. Recurring topics across this work include Aortic aneurysm repair treatments (3 papers), Gut microbiota and health (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Tendon Structure and Treatment (2 papers), Peptidase Inhibition and Analysis (2 papers), Gastric Cancer Management and Outcomes (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Nephrology (45 citations), Pharmacology (17 citations), Pulmonary and Respiratory Medicine (55 citations), Oncology (34 citations) and Molecular Biology (86 citations). Xiaofeng Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Gang Liu, Xueli Li, Jiayuan Zhao, Dayu Huang, Qinyun Ma, Huijun Zhang, Jilu Ye, Haotian Zhang, Jian Zhao and Guang‐Ming Liu. Their work appears in journals such as Current Microbiology, World Journal of Surgery, Non-coding RNA Research, Journal of Agricultural and Food Chemistry and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.